3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Abscess: new trials by email Literature Review of Abscess trials Research Report on Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotic Irrigations for Intra-Abdominal Drains Gentamicin Sulfate Inj 20mg/2ml vial for injection, Clindamycin phosphate 6 mg/1ml for injection, Placebo - Abdominal Abscess | Phase 2 | Terminated | University of Iowa | 2 | 2019-04-01 | 2026-09-03 |
| GSK2251052 in the Treatment of Complicated Intra-abdominal Infections Drug: GSK2251052, Meropenem, Placebo - Infections, Intestinal | Phase 2 | Terminated | GlaxoSmithKline | 15 | 2011-10-03 | 2017-11-29 |
| Safety and Effectiveness of tPA in Intra-abdominal Abscesses Tissue Plasminogen Activator, Normal Saline - Abscess | Phase 2 / Phase 3 | Terminated | University Health Network, Toronto | 35 | 2005-07-01 | 2014-01-14 |
Abdominal Abscess (1) · Infections (1) · Intraabdominal Infections (1) · Peritonitis (1)
Suppuration (3) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Digestive System Diseases (1) · Peritoneal Diseases (1)
3-(aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (1) · Injections (1) · Meropenem (1) · Saline Solution (1) · Tissue Plasminogen Activator (1) · clindamycin phosphate (1)
GlaxoSmithKline (1) · University Health Network, Toronto (1) · University of Iowa (1)
Canada (2) · United States (2) · Czechia (1) · France (1) · Italy (1) · Russia (1) · Spain (1)
Dheeraj Rajan, MD (1) · Murray Asch, MD (1) · Scott Sherman, MD (1)